Tuscaloosa, AL, United States of America

David Foster Mills

USPTO Granted Patents = 25 

Average Co-Inventor Count = 1.5

ph-index = 14

Forward Citations = 471(Granted Patents)


Location History:

  • Fort Worth, TX (US) (1999)
  • St. Petors, MO (US) (2005)
  • Littleton, CO (US) (2007)
  • Tuscaloosa, AL (US) (2001 - 2010)
  • St. Peters, MO (US) (2012)
  • Sugar Land, TX (US) (2006 - 2013)
  • San Antonio, TX (US) (2014)
  • North Bend, WA (US) (2015)
  • Monroe, LA (US) (2015 - 2019)
  • Newton, MA (US) (2017 - 2019)

Company Filing History:


Years Active: 1999-2025

Loading Chart...
25 patents (USPTO):Explore Patents

Title: Innovation and Contribution of Inventor David Mills in Antibody Development

Introduction

David Mills, an esteemed inventor based in Seattle, WA, has made significant contributions to the field of biochemistry and medical research. With one patent to his name, Mills has focused on developing advanced therapeutic solutions through innovative antibodies.

Latest Patents

David Mills holds a noteworthy patent titled "FN14 antibodies and uses thereof." This patent details an antibody or an antigen binding fragment that specifically binds to Fn14, acting as both an antagonist and non-agonist of Fn14. This innovation has the potential for diverse applications in treating conditions tied to Fn14 signaling.

Career Highlights

Mills is currently affiliated with Kyowa Kirin Co., Ltd., where he leverages his expertise to enhance research and development in antibody technologies. His work revolves around pioneering discoveries that advance therapeutic interventions, ensuring a positive impact on patient outcomes.

Collaborations

Throughout his career, David Mills has collaborated with talented colleagues such as Aihua Song and Andrew John McKnight. These partnerships exemplify his commitment to fostering innovation in the scientific community, enhancing the development of groundbreaking therapeutic solutions.

Conclusion

David Mills stands out as an inventor making important strides in the field of biotechnology. With his patent on FN14 antibodies, he exemplifies the spirit of innovation and dedication required to advance medical research. His work at Kyowa Kirin Co., Ltd. and collaborations with other professionals underscore his role in the ongoing quest for novel therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…